Latest Insider Transactions at Protara Therapeutics, Inc. (TARA)
This section provides a real-time view of insider transactions for Protara Therapeutics, Inc. (TARA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Protara Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Protara Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
300,000
+28.83%
|
$4,800,000
$16.87 P/Share
|
|
Nov 12
2019
|
Abingworth LLP |
BUY
Conversion of derivative security
|
Indirect |
126,645
+5.58%
|
$0
$0.99 P/Share
|
|
Nov 30
2017
|
James E Flynn Director |
SELL
Open market or private sale
|
Indirect |
110,557
-100.0%
|
$110,557
$1.75 P/Share
|
|
Nov 30
2017
|
James E Flynn Director |
BUY
Open market or private purchase
|
Indirect |
110,557
+35.9%
|
$110,557
$1.75 P/Share
|